Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies

BACKGROUND: On the basis of efficacy in mouse tumor models, multiple CD137 (4-1BB) agonist agents are being preclinically and clinically developed. The costimulatory molecule CD137 is inducibly expressed as a transmembrane or as a soluble protein (sCD137). Moreover, the CD137 cytoplasmic signaling d...

Descripción completa

Detalles Bibliográficos
Autores principales: Glez-Vaz, Javier, Azpilikueta, Arantza, Olivera, Irene, Cirella, Assunta, Teijeira, Alvaro, Ochoa, Maria C, Alvarez, Maite, Eguren-Santamaria, Iñaki, Luri-Rey, Carlos, Rodriguez-Ruiz, Maria E, Nie, Xinxin, Chen, Lieping, Guedan, Sonia, Sanmamed, Miguel F, Luis Perez Gracia, Jose, Melero, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896037/
https://www.ncbi.nlm.nih.gov/pubmed/35236742
http://dx.doi.org/10.1136/jitc-2021-003532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896037/
https://www.ncbi.nlm.nih.gov/pubmed/35236742
http://dx.doi.org/10.1136/jitc-2021-003532

Ejemplares similares